Chembio Diagnostics Profit Margin

The latest profit margin for CEMI is -51.56% as of December 2022. That compares with -91.81% in the prior-year period — up 43.8% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Chembio Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CEMI's profit margin moved from -91.81% to -51.56% — a 43.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chembio Diagnostics's valuation or profitability profile.

Against Healthcare companies, CEMI currently prints -51.56% for profit margin, while the sector average sits near 13.89%. That is roughly 471.2% below the sector mean. Large gaps often invite a closer look at Chembio Diagnostics's growth, margins, and balance sheet.

Profit Margin shows how effectively Chembio Diagnostics converts resources into returns. At -51.56%, CEMI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -91.81% in the prior-year period — up 43.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CEMI's profit margin (-51.56%), review year-over-year change from -91.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.